Patient characteristics and cardiovascular and mortality outcomes in patients with type 2 diabetes mellitus initiating treatment with sodium-glucose co-transporter-2 inhibitors and other antidiabetic medications in Finland

ENCePP Code of conduct

No

ENCePP Seal

Signed checklist for study protocols

ER-9565_ENCePPChecklistforStudyProtocols_Protocol version 1_ 20180504_signed

Data sources

• Data sources (types):
  Drug dispensing/prescription data

  Electronic healthcare records (EHR)

  Other
• Data sources (types), other:
  Causes of Death Registry, National Prescription Register including drug purchases and reimbursement decisions, National Hospital Care Register, National Primary Care Register, National register for institutionalizations (other than hospitalizations)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No